Real-time enrollment status for this cholangiocarcinoma clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 6:43 PM UTC
| NCT Number | NCT06777316 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Cholangiocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 110 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Cogent Biosciences, Inc. |
| Last Updated on CT.gov | April 17, 2026 (Apr 17, 2026) |
As of June 1, 2026: Clinical trial NCT06777316 is currently active_not_recruiting participants. This clinical trial study for cholangiocarcinoma is not currently accepting new participants at 13 locations across the United States. The study is sponsored by Cogent Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06777316 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06777316 was last updated Apr 17, 2026 (April 17, 2026). HelloStudys verifies this status automatically.